Recently, the mTOR pathway has been found to play a crucial role in the development of endometrial cancer with high frequency of mutations in PTEN and/or PIK3CA [18]; knowledge about genetic alterations involved in this pathway offer potential treatment strategies. Here, PIK3CA is linked to endometrial cancer.